Association of RAMP-1 gene polymorphisms and risk of migraine: Systemic review and meta-analysis

[1]  D. Dodick,et al.  Migraine research comes of age in the 21st century , 2022, The Lancet Neurology.

[2]  Jatin Gupta,et al.  Migraine: An Underestimated Neurological Condition Affecting Billions , 2022, Cureus.

[3]  A. Ponte-Sucre,et al.  G Protein-Coupled Receptors as Potential Intercellular Communication Mediators in Trypanosomatidae , 2022, Frontiers in Cellular and Infection Microbiology.

[4]  G. Riccitelli,et al.  Clinic and genetic predictors in response to erenumab , 2021, European journal of neurology.

[5]  Sindhu Varghese,et al.  Association of VEGF polymorphisms and breast cancer susceptibility: Systemic review and meta-analysis , 2021 .

[6]  S. Kumar,et al.  LDLR, MTHFR and KLOTHO gene polymorphisms as an early predictor in the risk of coronary artery disease: A meta-analysis , 2021 .

[7]  Gayathri Natarajan,et al.  Association of interleukin1β, interleukin1 receptor antagonist, interleukin 6 and angiotensin II receptor type I gene polymorphisms with end stage renal disease: A meta-analysis , 2020 .

[8]  S. Kumar,et al.  Association of Interleukin 6 and insulin resistance gene polymorphism with polycystic ovarian syndrome: A meta-analysis , 2020 .

[9]  J. Olesen,et al.  No central action of CGRP antagonising drugs in the GTN mouse model of migraine , 2020, Cephalalgia : an international journal of headache.

[10]  S. Kumar,et al.  Association between genetic variants of NOS3, TGF-β and susceptibility of diabetic nephropathy: A meta-analysis , 2019, Meta Gene.

[11]  R. Lipton,et al.  Migraine Progression: A Systematic Review , 2018, Headache.

[12]  P. Gazerani.  Current Evidence on the Role of Epigenetic Mechanisms in Migraine: The Way Forward to Precision Medicine , 2018, OBM Genetics.

[13]  D. Hay,et al.  Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25 , 2018, British journal of pharmacology.

[14]  A. Szallasi,et al.  Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field , 2017, British journal of pharmacology.

[15]  Shiek S. S. J. Ahmed,et al.  Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: A meta-analysis , 2017, Journal of Neuroimmunology.

[16]  Shiek S. S. J. Ahmed,et al.  Association of rs1801582 and rs1801334 PARK2 Polymorphisms with risk of Parkinson's disease: A case-control study in South India and Meta-Analysis , 2016 .

[17]  V. Ramakrishnan,et al.  Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: a meta-analysis , 2016, Journal of the Neurological Sciences.

[18]  R. Cantello,et al.  Association of RAMP1 rs7590387 With the Risk of Migraine Transformation Into Medication Overuse Headache , 2015, Headache.

[19]  I. M. Bell.  Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine. , 2014, Journal of medicinal chemistry.

[20]  L. Haupt,et al.  Association study of the calcitonin gene-related polypeptide-alpha (CALCA) and the receptor activity modifying 1 (RAMP1) genes with migraine. , 2013, Gene.

[21]  F. Ahmed.  Headache disorders: differentiating and managing the common subtypes , 2012, British journal of pain.

[22]  Blair H. Smith,et al.  Epidemiology of Neuropathic Pain and Its Impact on Quality of Life , 2012, Current Pain and Headache Reports.

[23]  D. Hay,et al.  Regulation of signal transduction by calcitonin gene-related peptide receptors. , 2010, Trends in pharmacological sciences.

[24]  T. Nakayama,et al.  Haplotype-based case–control study of receptor (calcitonin) activity-modifying protein-1 gene in cerebral infarction , 2010, Journal of Human Hypertension.

[25]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[26]  R. Lea,et al.  No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. , 2001, American journal of medical genetics.

[27]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[28]  Q. Lin,et al.  Association of CALCA and RAMP 1 gene polymorphisms with migraine in a Chinese population , 2017 .

[29]  M. Kawamura,et al.  Lack of association between CGRP-related gene polymorphisms and medication overuse headache in migraine patients , 2015 .